|
[1]MUNSHI A,RAMESH R.Mitogen-activated protein kinases and their role in radiation response[J].Genes Cancer,2013,4(9-10):401-408.
|
|
[2]LI JF,DENG YD,ZHANG LT,et al.The role of Ras/ERK signal transduction pathway in the occurrence and development of hepatic fibrosis[J].J Clin Hepatol,2011,27(3):325-327.(in Chinese)李俊峰,邓永东,张立婷,等.Ras/ERK信号转导通路在肝纤维化发生发展中的作用[J].临床肝胆病杂志,2011,27(3):325-327.
|
|
[3]DELIRE B,STARKEL P.The Ras/MAPK pathway and hepatocarcinoma:pathogenesis and therapeutic implications[J].Eur J Clin Invest,2015,45(6):609-623.
|
|
[4]HAN T,XIANG D M,SUN W,et al.PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patients[J].J hepatol,2015,63(3):651-660.
|
|
[5]BERASAIN C,NICOU A,GARCIA-IRIGOYEN O,et al.Epidermal growth factor receptor signaling in hepatocellular carcinoma:inflammatory activation and new intracellular regulatory mechanism[J].Dig Dis,2012,30(5):524-531.
|
|
[6]YANG L,ZHAO LY,LIU YC,et al.CB1 and ERK gene expression in liver tissue of rats with experimental hepatic fibrosis[J].J Clin Hepatol,2012,28(9):681-684.(in Chinese)杨莉,赵连英,刘彦超,等.大麻素受体1和细胞外信号调节激酶在肝纤维化小鼠肝组织中的表达及意义[J].临床肝胆病杂志,2012,28(9):681-684.
|
|
[7]WANG HY,YANG SL,LIANG HF,et al.HBx protein promotes oval cell proliferation by up-regulation of cyclin D1 via activation of the MEK/ERK and PI3K/Aktpathways[J].Int J Mol Sci,2014,15(3):3507-3518.
|
|
[8]YE H,ZHANG C,WANG BJ,et al.Synergistic function of Kras mutation and HBx in initiation and progression of hepatocellular carcinoma in mice[J].Oncogene,2014,33(43):5133-5138.
|
|
[9]NAKAMURA H,AOKI H,HINO O,et al.HCV core protein promotes heparin binding EGF-like growth factor expression and activates Akt[J].Hepatol Res,2011,41(5):455-462.
|
|
[10]XIE B,XING R,CHEN P,et al.Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference[J].J Surg Res,2010,162(2):231-238.
|
|
[11]ZHOU P,HUANG G,ZHAO Y,et al.MicroRNA-363-mediated downregulation of S1PR1 suppresses the proliferation of hepatocellular carcinoma cells[J].Cell Signal,2014,26(6):1347-1354.
|
|
[12]KOUL KH,PAL M,KOUL S,et al.Role of p38 MAP kinase signal transduction in solid tumors[J].Genes Cancer,2013,4(9-10):342-359.
|
|
[13]ESCOS A,RISCO A,ALSINA-BEAUCHAMP D,et al.p38gamma and p38delta mitogen activated protein kinases(MAPKs),new stars in the MAPK galaxy[J].Front Cell Dev Biol,2016,4:31-38.
|
|
[14]CHEN KC,CHANG LS.Notexin upregulates Fas and Fas L protein expression of human neuroblastoma SK-N-SH cells through p38MAPK/ATF-2 and JNK/c-Jun pathways[J].Toxicon,2010,55(4):754-761.
|
|
[15]AMAKO Y,IGLOI Z,MANKOURI J,et al.Hepatitis C virus NS5A inhibits mixed lineage kinase3 to block apoptosis[J].J Biol Chem,2013,288(34):24753-24763.
|
|
[16]SONG MK,PARK YK,RYU JC.Polycyclic aromatic hydrocarbon(PAH)-mediated upregulation of hepatic microRNA-181 family promotes cancer cellmigration by targeting MAPK phosphatase-5,regulating the activation of p38 MAPK[J].Toxicol Appl Pharmacol,2013,273(1):130-139.
|
|
[17]YIN J,WANG L,ZHU JM,et al.Prp19 facilitates invasion of hepatocellular carcinoma via p38 mitogen-activated protein kinase/twist1 pathway[J].Oncotarget,2016,7(16):21939-21951.
|
|
[18]YARZA R,VELA S,SOLAS M,et al.c-Jun N-terminal Kinase(JNK)Signaling as a therapeutic target for Alzheimer's disease[J].Front pharmacol,2016,6:321.
|
|
[19]JIANGX,KANDA T,WU S,et al.Regulation of microRNA by hepatitis B virus infection and their possible association with control of innate immunity[J].World J Gastroenterol,2014,20(23):7197-7206.
|
|
[20]KIM S,ISHIDA H,YAMANE D,et al.Contrastin roles of mitogen-activated protein kinases in cellular entry and replication of hepatitis C virus:MKNK1facilitates cell entry[J].J Virol,2013,87(8):4214-4224.
|
|
[21]ZHANG YH,WANG SQ,SUN CR,et al.Inhibition of JNK1 expression decreases migration and invasion of mouse hepatocellular carcinoma cell line in vitro[J].Med Oncol,2011,28(4):966-972.
|
|
[22]NI Z,WANG B,DAI X,et al.HCC cells with high levels of Bcl-2 are resistant to ABT-737 via activation of the ROS-JNK-autophagy pathway[J].Free Radic Biol Med,2014,70:194-203.
|
|
[23]KOMODA F,SHINO Y,HIRNO T,et al.MEKK1 induces c-Jun complexes that act as negative regulators for cell survival and proliferation of HCC cells[J].Int J Oncol,2002,21(3):553-559.
|
|
[24]ZHONG C,LI HD,LIU DY,et al.Clinical study of hepatectomy combined with jianpi huayu therapy for hepatocellular carcinoma[J].Asian Pac J Cancer Prev,2014,15(14):5951-5957.
|
|
[25]ZHANG Z,ZHOU X,SHEN H,et al.Phosphorylated ERK is a potential predictor of sensitivity to sorafenib when treating hepatocellular carcinoma:evidence from an in vitro study[J].BMC Med,2009,24(7):41-53.
|
|
[26]GOPALAN B,NARAYANAN K,KE Z,et al.Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma[J].Biomaterials,2014,35(26):7479-7487.
|
|
[27]ZHANG Z,MIAO L,LV C,et al.Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells[J].Cell Death Dis,2013,4(6):e657-e679.
|
|
[28]ZHANG J,LAN SJ,LIU QR,et al.Neuroglobin,a novel intracellular hexa-coordinated globin,functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk[J].Mol Pharmacol,2013,83(5):1109-1119.
|
|
[29]PUSHPAVALLIS S,RAMAIAH MJ,SRINIVAS CH,et al.Effect of Benzothiazole based conjugates in causing apoptosis by Regulating p53,PTEN and MAP Kinase proteins affecting miR-195a and miR-101-1[J].Cancer Cell Int,2011,11(1):36-39.
|
|
[30]LIU J,WEI X,WU Y,et al.Giganteaside D induces ROS-mediated apoptosis in human hepatocellular carcinoma cells through the MAPK pathway[J].Cellular oncology(Dordrecht),2016.[Epub ahead of print]
|
|
[31]ZHU H,CHEN XP,LUO SF,et al.The role of extracellular signalregulated kinase pathway in multidrug resistance of hepatocellular carcinoma[J].Chin J Surg,2007,45(13):917-920.(in Chinese)朱虹,陈孝平,罗顺峰,等.ERK/MAPK通路参与肝癌产生多药耐药的胞内信号传导[J].中华外科杂志,2007,45(13):917-920.
|
|
[32]XI Q,GAO N,YANG Y,et al.Anticancer drugs induce hypomethylation of the acetylcholinesterase promoter via a phosphorylated-p38-DNMT1-ACh E pathway in apoptotic hepatocellular carcinoma cells[J].Int J Biochem Cell Biol,2015,68(11):21-32.
|
|
[33]HUANG G,TANG B,TANG K,et al.Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway[J].Oncol Rep,2014,31(5):2377-2384.
|
|
[34]LIU J,WEN X,LIU B,et al.Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP2 and MMP9[J].Mol Med Reps,2016,13(3):2401-2408.
|
|
[35]LIAO YJ,BAI HY,LI ZH,et al.Longikaurin A,a natural ent-kaurane,induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells[J].Cell Death Dis,2014,5(3):e1137.
|
|
[36]TAN J,LAI Z,LIU L,et al.ONTD induces apoptosis of human hepatoma Bel-7402 cells via a MAPK-dependent mitochondrial pathway and the depletion of intracellular glutathione[J].Int J Biochem Cell Biol,2013,45(11):2632-2642.
|
|
[37]YAN F,WANG XM,LIU ZC,et al.JNK1,JNK2,and JNK3 are involved in P-glycoprotein-mediated multidrug resistance of hepatocellular carcinoma cells[J].Hepatobiliary Pancreat Dis Int,2010,9(3):287-295.
|
|
[38]HAGIWARA S,KUDO M,NAGAI T,et al.Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma[J].Br J Cancer,2012,106(12):1997-2003.
|
|
[39]CHEN L,SHI Y,JIANG CY,et al.Expression and prognostic role of pan-Ras,Raf-1,p MEK1 and p ERK1/2 in patients with hepatocellular carcinoma[J].Eur J Surg Oncol,2011,37(6):513-520.
|
|
[40]WANG SN,LEE KT,TSAI CJ,et al.Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma[J].Eur J Clin Invest,2012,42(12):1295-1301.
|
|
[41]HAGIWARA S,KUDO M,CHUNG H,et al.Activation of c-Jun N-terminal kinase in non-cancerous liver tissue predicts a high risk of recurrence after hepatic resection for hepatocellular carcinoma[J].Hepatol Res,2012,42(4):394-400.
|
DownLoad: